Who, what and when – effective therapy for severe COVID-19 – Community News
Covid-19

Who, what and when – effective therapy for severe COVID-19

The COVID-19 pandemic is underway and the SARS-CoV-2 delta variant has led to a resurgence of the disease. As many as 20% of people infected with SARS-CoV-2 suffer from hyperinflammatory COVID-19, resulting in hospitalization with COVID-19 pneumonia.

1

  • Henderson LA
  • Canna SW
  • Schulert GS
  • et al.
Alert to cytokine storm: immunopathology in COVID-19.